Ji Hyun Lee1, Kristi E Gamarel2, Christopher W Kahler1, Brandon D L Marshall1, Jacob J van den Berg3, Kendall Bryant4, Nickolas D Zaller5, Don Operario6. 1. School of Public Health, Brown University, Providence, RI, USA. 2. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA. 3. Division of Infectious Diseases, Miriam Hospital and Alpert Medical School of Brown University, Providence, RI, USA. 4. National Institute on Alcohol Abuse and Alcoholism, Rockville, MD, USA. 5. Fay W. Boozman College of Public Health, University of Arkansas, Little Rock, AR, USA. 6. School of Public Health, Brown University, Providence, RI, USA. Electronic address: Don_Operario@brown.edu.
Abstract
BACKGROUND: Emerging evidence indicates multiple health risks associated with harmful alcohol use among sexual minority men in the United States. In particular, sexual minority men with alcohol use disorders (AUD) might have greater co-occurring health problems compared with heterosexual men. We used nationally representative data to compare the prevalence of diagnostic co-occurring psychiatric disorders and drug use disorders (DUD) among sexual minority men with AUD compared with heterosexual males with a lifetime AUD diagnosis. METHODS: We analyzed data from 6899 adult males with AUD participating in Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Using weighted multivariable logistic regression models, we compared the odds of lifetime diagnosis of mood disorders, anxiety disorders, and drug use disorders in sexual minority and heterosexual adult males with AUD. RESULTS: Of participants included in this analysis, 176 (2.6%) self-identified as a sexual minority. In adjusted analyses, sexual minority men with AUD were more likely than heterosexual men with AUD to have any mood disorder (including major depressive episode), any anxiety disorder (including panic disorder without agoraphobia, specific phobia, posttraumatic stress disorder, and generalized anxiety disorder), and lifetime DUD. CONCLUSIONS: The elevated co-occurrence of psychiatric disorders and DUD among sexual minority men with AUD suggests that future research is warranted. A better understanding of the etiology of diagnostic co-occurring mental health and substance use disorders among sexual minority men is needed in order to develop effective integrated prevention and treatment programs.
BACKGROUND: Emerging evidence indicates multiple health risks associated with harmful alcohol use among sexual minority men in the United States. In particular, sexual minority men with alcohol use disorders (AUD) might have greater co-occurring health problems compared with heterosexual men. We used nationally representative data to compare the prevalence of diagnostic co-occurring psychiatric disorders and drug use disorders (DUD) among sexual minority men with AUD compared with heterosexual males with a lifetime AUD diagnosis. METHODS: We analyzed data from 6899 adult males with AUD participating in Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Using weighted multivariable logistic regression models, we compared the odds of lifetime diagnosis of mood disorders, anxiety disorders, and drug use disorders in sexual minority and heterosexual adult males with AUD. RESULTS: Of participants included in this analysis, 176 (2.6%) self-identified as a sexual minority. In adjusted analyses, sexual minority men with AUD were more likely than heterosexual men with AUD to have any mood disorder (including major depressive episode), any anxiety disorder (including panic disorder without agoraphobia, specific phobia, posttraumatic stress disorder, and generalized anxiety disorder), and lifetime DUD. CONCLUSIONS: The elevated co-occurrence of psychiatric disorders and DUD among sexual minority men with AUD suggests that future research is warranted. A better understanding of the etiology of diagnostic co-occurring mental health and substance use disorders among sexual minority men is needed in order to develop effective integrated prevention and treatment programs.
Authors: Sean Esteban McCabe; Wendy B Bostwick; Tonda L Hughes; Brady T West; Carol J Boyd Journal: Am J Public Health Date: 2010-01-14 Impact factor: 9.308
Authors: Bryan Hartzler; Beatriz H Carlini; Howard Newville; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan Journal: AIDS Care Date: 2016-12-23
Authors: Bradley T Kerridge; Roger P Pickering; Tulshi D Saha; W June Ruan; S Patricia Chou; Haitao Zhang; Jeesun Jung; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2016-11-07 Impact factor: 4.492
Authors: Jennifer K Felner; Sean J Haley; Hee-Jin Jun; Jennifer P Wisdom; Laura Katuska; Heather L Corliss Journal: Addict Behav Date: 2021-01-07 Impact factor: 3.913
Authors: Hee-Jin Jun; Megan Webb-Morgan; Jennifer K Felner; Jennifer P Wisdom; Sean J Haley; S Bryn Austin; Laura M Katuska; Heather L Corliss Journal: Drug Alcohol Depend Date: 2019-10-17 Impact factor: 4.492